rs12764271

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_201596.3(CACNB2):​c.-259C>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.074 in 151,846 control chromosomes in the GnomAD database, including 560 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.074 ( 560 hom., cov: 33)

Consequence

CACNB2
NM_201596.3 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.864

Publications

0 publications found
Variant links:
Genes affected
CACNB2 (HGNC:1402): (calcium voltage-gated channel auxiliary subunit beta 2) This gene encodes a subunit of a voltage-dependent calcium channel protein that is a member of the voltage-gated calcium channel superfamily. The gene product was originally identified as an antigen target in Lambert-Eaton myasthenic syndrome, an autoimmune disorder. Mutations in this gene are associated with Brugada syndrome. Alternatively spliced variants encoding different isoforms have been described. [provided by RefSeq, Feb 2013]
CACNB2 Gene-Disease associations (from GenCC):
  • Brugada syndrome 4
    Inheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Genomics England PanelApp
  • cardiogenetic disease
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • short QT syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 10-18140478-C-A is Benign according to our data. Variant chr10-18140478-C-A is described in ClinVar as Benign. ClinVar VariationId is 674367.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.115 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_201596.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNB2
NM_201596.3
MANE Select
c.-259C>A
5_prime_UTR
Exon 1 of 14NP_963890.2Q08289-1
CACNB2
NM_201597.3
c.-259C>A
5_prime_UTR
Exon 1 of 14NP_963891.1Q08289-8
CACNB2
NM_201571.4
c.-702C>A
5_prime_UTR
Exon 1 of 14NP_963865.2Q08289-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNB2
ENST00000324631.13
TSL:1 MANE Select
c.-259C>A
5_prime_UTR
Exon 1 of 14ENSP00000320025.8Q08289-1

Frequencies

GnomAD3 genomes
AF:
0.0740
AC:
11232
AN:
151736
Hom.:
560
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0187
Gnomad AMI
AF:
0.149
Gnomad AMR
AF:
0.119
Gnomad ASJ
AF:
0.0435
Gnomad EAS
AF:
0.00893
Gnomad SAS
AF:
0.100
Gnomad FIN
AF:
0.107
Gnomad MID
AF:
0.0892
Gnomad NFE
AF:
0.0960
Gnomad OTH
AF:
0.0777
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0740
AC:
11235
AN:
151846
Hom.:
560
Cov.:
33
AF XY:
0.0745
AC XY:
5531
AN XY:
74222
show subpopulations
African (AFR)
AF:
0.0186
AC:
773
AN:
41506
American (AMR)
AF:
0.119
AC:
1818
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.0435
AC:
151
AN:
3470
East Asian (EAS)
AF:
0.00895
AC:
46
AN:
5138
South Asian (SAS)
AF:
0.100
AC:
482
AN:
4818
European-Finnish (FIN)
AF:
0.107
AC:
1124
AN:
10484
Middle Eastern (MID)
AF:
0.0890
AC:
26
AN:
292
European-Non Finnish (NFE)
AF:
0.0960
AC:
6517
AN:
67874
Other (OTH)
AF:
0.0769
AC:
162
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
535
1070
1606
2141
2676
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
132
264
396
528
660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0762
Hom.:
79
Bravo
AF:
0.0712
Asia WGS
AF:
0.0460
AC:
159
AN:
3458

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
9.3
DANN
Benign
0.77
PhyloP100
-0.86
PromoterAI
-0.0076
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12764271; hg19: chr10-18429407; API